Investors & Media

analyst coverage

Firm Analyst
Bank of America Merrill Lynch
Ying Huang
Bernstein
Vincent Chen
Bernstein
Vincent Chen
BMO Capital Markets
Matthew Luchini
BMO Capital Markets
Matthew Luchini
BTIG
Dane Leone
Cantor Fitzgerald
Elemer Piros Ph.D.
Cowen
Eric Schmidt Ph.D.
Goldman Sachs
Salveen Richter
J.P. Morgan
Cory Kasimov
Janney Montgomery
Debjit Chattopadhyay Ph.D.
Jefferies
Gena Wang
Leerink
Michael Schmidt Ph.D.
Maxim Group
Jason McCarthy Ph.D.
Morgan Stanley
Matthew Harrison
Piper Jaffray
Joshua Schimmer M.D.
ROTH Capital Partners
Mark Breidenbach
SunTrust Robinson Humphrey
Edward Nash
Wedbush PacGrowth Life Sciences
David Nierengarten Ph.D.
Wells Fargo
Jim Birchenough

bluebird bio, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding bluebird bio, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of bluebird bio, Inc. or its management. bluebird bio, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Investor Contact

Manisha Pai

Sr. Director, Investor Relations

(617) 245-2107

investor@bluebirdbio.com

 

Media Contact

Elizabeth Pingpank

Associate Director, Corporate Communications

(617) 914-8736

EPingpank@bluebirdbio.com